Infliximab treatment for Crohn's disease

Authors:

Abstract
The advent of a therapy that can potentially restore immunological imbalance, modify the disease, and prolong remission in Crohn's disease patients, has thus been eagerly awaited.

This publication has 38 references indexed in Scilit: